Keyphrases
Diagnostic Test
50%
Early Liver Transplantation
50%
Liver Decompensation
50%
Alcoholic Hepatitis
50%
Dextran Sulfate Sodium-induced Colitis
50%
Interleukin-17 (IL-17)
50%
Metabolic
50%
Randomized Controlled Trial
50%
Gastrointestinal Diseases
50%
Aerobic Training
50%
Signal Transducer and Activator of Transcription 3
50%
Laboratory Testing
50%
Liver Histology
50%
Cirrhosis
50%
Clinical Outcomes
50%
Transarterial Chemoembolization
50%
Liver Function
50%
Hepatocellular Carcinoma
50%
Liver Transplantation
50%
Steatohepatitis
33%
Exercise Training
33%
Gastrointestinal Tract
25%
Diagnostic Imaging
25%
Diagnostic Endoscopy
25%
Diagnostic Modalities
25%
Liver
21%
Splenocytes
16%
Liver Fat
16%
Cardiometabolic Risk
16%
Mechanistic Pathway
16%
Imaging Biomarkers
16%
Clinical Endpoints
16%
Quality of Life
16%
Specific Goals
16%
Differential Impact
16%
Serum Biomarkers
16%
Regular Physical Activity
16%
Randomized Controlled Clinical Trial
16%
Chronic Liver Disease
16%
Harmful Drinking
14%
Colitis
12%
Delisting
10%
In Vivo Applications
8%
Statistical Analysis
5%
Poor Outcome
5%
Multinomial Model
5%
Hospitalization
5%
Retrospective Cohort Study
5%
Locoregional Therapy
5%
Clinical Stability
5%
Medicine and Dentistry
Liver Transplantation
100%
Decompensated Liver Cirrhosis
55%
Exercise
50%
Randomized Controlled Trial
50%
Laboratory Testing
50%
Liver Histology
50%
Aerobic Exercise
50%
Liver Cirrhosis
50%
Hepatocellular Carcinoma
50%
Transcatheter Arterial Chemoembolization
50%
Liver Function
50%
Biological Marker
33%
Steatohepatitis
33%
Cardiometabolic Risk
16%
Alcohol Consumption
16%
Quality of Life
16%
Liver Disease
16%
Physical Activity
16%
Chronic Liver Disease
16%
Controlled Clinical Trial
16%
Magnetic Resonance Imaging
16%
Fatty Liver
16%
Hazard Ratio
8%
Transplantation
5%
Retrospective Cohort Study
5%
Pharmacology, Toxicology and Pharmaceutical Science
Triterpenoid
50%
Dextran Sulfate Sodium-Induced Colitis
50%
STAT3 Protein
50%
Biological Marker
50%
Randomized Controlled Trial
50%
Interleukin 17
50%
Liver Cirrhosis
50%
Liver Cell Carcinoma
50%
Liver Disease
25%
Chronic Liver Disease
25%
Controlled Clinical Trial
25%
Fatty Liver
25%
Colitis
20%
Cohort Study
16%
Decompensated Liver Cirrhosis
16%
Dextran Sulfate
8%
